Latest news

Additional study into COVID-19-care by general practitioner

The study, which is an extension of the DCVA COVID@HEART study, is focused on people who get COVID-19 but are not hospitalized.

What are the plans of the Dutch CardioVascular Alliance in 2021?

First FIRST-fund investment in potential medicine for stroke

Two years in alliance

Two years ago, the Dutch CardioVascular Alliance was officially launched. Let's take a trip down memory lane, and look back at some of the highlights.

Young@heart played an active part in record breaking ESC

In close collaboration with the ESC Scientists and Clinicians of Tomorrow,Young@Heart designed hundreds of cutting edge scientific sessions for this year's ESC congress, which turned out to become a record-breaking event.

Meet three new partners

Earlier this year, the DCVA gained three valuable partners. Learn what these three parties stand for, how they are valuable to the DCVA, and how the DCVA is valuable to them.

Start of the DCVA Leadership Program 2020

The first edition of the DCVA Leadership Program officially started. During three days of training and social interaction Margreet van Rixtel trained the fifteen participants in taking their first steps of becoming leaders who are able to solve complex current healthcare related problems.

DCVA COVID-19 update

Are COVID-19 patients at increased risk to develop ischemic stroke and what are the first results of CAPACITY? In this update, we present the new COVID-19 project STROCORONA and the first results of CAPACITY.

New implementation consortium CUSTOM-AF

Preventing cerebral infarctions caused by atrial fibrillation. That is the main goal of the implementation consortium CUSTOM-AF.

Meet the partners

In this sixth and final edition of Meet the partners, we interview leaders of two of these partners, namely Floris Italianer (left), CEO of the Dutch Heart Foundation and prof. dr. Arno Hoes (right), dean of the Faculty of Medicine of the UMC Utrecht and formal prepresentative of the NFU.

4th Translational Cardiovascular Research Meeting

Although the setup was a little different than that of the former three editions, the congress was again well received.

Join Y@H or become a mentor

To strengthen our cardiovascular talent community, we invite PhD students and post-docs to actively participate in Young@Heart activities.

Help us review the EU blueprint

The ESC and the EHN have launched a blueprint for EU action against cardiovascular disease. We invite researchers and leaders in the field to read the this document and share your insights. 

Hospitals sought for Valsartan study

Can Valsartan prevent serious accumulation of fluid in the lungs in COVID-19? To answer this question, the Dutch Cardiovascular Alliance started the Praetorian COVID study. Initiators and research leaders Niels van Royen and Roland van Kimmenade (Radboudumc) are urging colleagues from other hospitals to participate.

COVID-19 research: avoid duplication

Avoid duplication, combine efforts, maximise results, register your COVID-studies now

DCVA supports studies

Given the strong correlation and potentially deadly entanglement of COVID-19 and cardiovascular diseases, the DCVA decided to support two research studies

Strategy meeting 

How nephrology and cardiology share common goals, what COVID-19 teaches us about working together with fifteen partners, three dilemmas and no socialising during drinks and dinner: those were the highlights of our first online but vivid strategy meeting on 1 April.

Meet the partners

In this fifth edition of Meet the partners we interview Niek Dubelaar LLM MSc (left), Head of Knowledge Transfer Office of KNAW and Dr. ir. Herry Nijhuis (right), Director NWO Applied and Engineering Sciences (TTW).

CAPACITY COVID REGISTRY

COVID-19 patients with cardiovascular disease are an extremely vulnerable population. To give these patients the best possible care and to be prepared for future outbreaks, we need to know more about these patients and the best practices for treating them. Therefore DCVA partners launched the CAPACITY COVID Registry.

DCVA & RegMedXB fund launched

Launch of fund to accelerate development of solutions for prevention and cure of chronic diseases ensuring patients benefit earlier